Sat, Sep 20, 2014, 11:42 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Jan 9, 2013 5:33 PM Flag

    IST early results:hormonal agent combo trial


    To the best of my knowledge, this can only be the Dana-Farber Zytiga combo trial...and EXEL must be pleased w/ the results if they are willing to pay for further study. This is good news...and further confirms the intended usage in a pre-chemo setting.

1.70-0.02(-1.16%)Sep 19 4:15 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.